Receptor expression modulates the specificity of transforming growth factor-β signaling pathways

Genes to Cells

Volumn 14, Issue 4, 2009, Pages 469-482

  Murakami, Masaru ^a   Kawachi, Hiroyuki ^b   Ogawa, Kenji ^c   Nishino, Yoshii ^a   Funaba, Masayuki ^a,b  

^a AZABU UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c RIKEN   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; ACTIVIN RECEPTOR LIKE KINASE 1; ACTIVIN RECEPTOR LIKE KINASE 4; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; INHIBITOR OF DIFFERENTIATION 1; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN SERINE THREONINE KINASE; RECEPTOR REGULATED SMAD PROTEIN; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL STRAIN HEPG2; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME SPECIFICITY; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION;

ACTIVIN RECEPTORS, TYPE I; ANIMALS; BLOTTING, WESTERN; BONE MORPHOGENETIC PROTEIN 2; CELL LINE; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; HELA CELLS; HUMANS; IMIDAZOLES; IMMUNOPRECIPITATION; MICE; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PYRIDINES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SMAD PROTEINS, RECEPTOR-REGULATED; TRANSFORMING GROWTH FACTOR BETA1;

EID: 63349097519     PISSN: 13569597     EISSN: 13652443     Source Type: Journal    
DOI: 10.1111/j.1365-2443.2009.01283.x     Document Type: Article

References (37)

1. Attisano, L. & Wrana, J.L. (2002) Signal transduction by the TGF-β superfamily. Science 296, 1646-1647.
2. Bilezikjian, L.M., Blount, A.L., Donaldson, C.J. & Vale, W.W. (2006) Pituitary actions of ligands of the TGF-β family: Activins and inhibins. Reproduction 132, 207-215.
3. Callahan, J.F., Burgess, J.L., Fornwald, J.A., Gaster, L.M., Harling, J.D., Harrington, F.P., Heer, J., Kwon, C., Lehr, R., Mathur, A., Olson, B.A., Weinstock, J. & Laping, N.J. (2002) Identification of novel inhibitors of the transforming growth factor β1 (TGF-β1) type 1 receptor (ALK5). J. Med. Chem. 45, 999-1001.
4. Chang, H., Brown, C.W. & Matzuk, M.M. (2002) Genetic analysis of the mammalian transforming growth factor-β superfamily. Endocr. Rev. 23, 787-823.
5. Chen, R.H., Moses, H.L., Maruoka, E.M., Derynck, R. & Kawabata, M. (1995) Phosphorylation-dependent interaction of the cytoplasmic domains of the type I and type II transforming growth factor-β receptors. J. Biol. Chem. 270, 12235-12241.
6. Chen, H.B., Shen, J., Ip, Y.T. & Xu, L. (2006) Identification of phosphatases for Smad in the BMP/DPP pathway. Genes Dev. 20, 648-653.
7. Chen, F. & Weinberg, R.A. (1995) Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor β receptor kinases. Proc. Natl. Acad. Sci. USA 92, 1565-1569.
8. Chorostowska-Wynimko, J., Skrzypczak-Jankun, E. & Jankun, J. (2004) Plasminogen activator inhibitor type-1: Its structure, biological activity and role in tumorigenesis. Int. J. Mol. Med. 13, 759-766.
9. Daly, A.C., Randall, R.A. & Hill, C.S. (2008) Transforming growth factor β-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth. Mol. Cell. Biol. 28, 6889-6902.
10. ten Dijke, P., Yamashita, H., Ichijo, H., Franzen, P., Laiho, M., Miyazono, K. & Heldin, C.H. (1994) Characterization of type I receptors for transforming growth factor-β and activin. Science 264, 101-104.
11. Feng, X.H. & Derynck, R. (1996) Ligand-independent activation of transforming growth factor (TGF) β signaling pathways by heteromeric cytoplasmic domains of TGF-β receptors. J. Biol. Chem. 271, 13123-13129.
12. Feng, X.H. & Derynck, R. (2005) Specificity and versatility in TGF-β signaling through Smads. Annu. Rev. Cell Dev. Biol. 21, 659-693.
13. Funaba, M., Ikeda, T., Murakami, M., Ogawa, K., Tsuchida, K., Sugino, H. & Abe, M. (2003) Transcriptional activation of mouse mast cell protease-7 by activin and transforming growth factor-β is inhibited by microphthalmia-associated transcription factor. J. Biol. Chem. 278, 52032-52041.
14. Funaba, M. & Mathews, L.S. (2000) Recombinant expression and purification of Smad proteins. Protein Expr. Purif. 20, 507-513.
15. Funaba, M. & Murakami, M. (2008) A sensitive detection of phospho-Smad1/5/8 and Smad2 in Western blot analyses. J. Biochem. Biophys. Methods 70, 816-819.
16. Funaba, M., Nakaya, K., Ikeda, T., Murakami, M., Tsuchida, K. & Sugino, H. (2006) Requirement of Smad3 for mast cell growth. Cell. Immunol. 240, 47-52.
17. Goumans, M.J., Valdimarsdottir, G., Itoh, S., Lebrin, F., Larsson, J., Mummery, C., Karlsson, S. & ten Dijke, P. (2003) Activin receptor-like kinase (ALK) 1 is an antagonistic mediator of lateral TGFβ/ALK5 signaling. Mol. Cell 12, 817-828.
18. Goumans, M.J., Valdimarsdottir, G., Itoh, S., Rosendahl, A., Sideras, P. & ten Dijke, P. (2002) Balancing the activation state of the endothelium via two distinct TGF-β type I receptors. EMBO J. 21, 1743-1753.
19. Gupta, P.B., Mani, S., Yang, J., Hartwell, K. & Weinberg, R.A. (2005) The evolving portrait of cancer metastasis. Cold Spring Harb. Symp. Quant. Biol. 70, 291-297.
20. Hua, X., Miller, Z.A., Wu, G., Shi, Y. & Lodish, H.F. (1999) Specificity in transforming growth factor β-induced transcription of the plasminogen activator inhibitor-1 gene: Interactions of promoter DNA, transcription factor μE3, and Smad proteins. Proc. Natl. Acad. Sci. USA 96, 13130-13135.
21. Inman, G.J., Nicolas, F.J., Callahan, J.F., Harling, J.D., Gaster, L.M., Reith, A.D., Laping, N.J. & Hill, C.S. (2002) SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 62, 65-74.
22. Korchynskyi, O. & ten Dijke, P. (2002) Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J. Biol. Chem. 277, 4883-4891.
23. Kowanetz, M., Valcourt, U., Bergström, R., Heldin, C.H. & Moustakas, A. (2004) Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor β and bone morphogenetic protein. Mol. Cell. Biol. 24, 4241-4254.
24. Liu, I.M., Schilling, S.H., Knouse, K.A., Choy, L., Derynck, R. & Wang, X.F. (2009) TGFβ-stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro-migratory TGFβ switch. EMBO J. 28, 88-98.
25. Ma, D., Gerard, R.D., Li, X.Y., Alizadeh, H. & Niederkorn, J.Y. (1997) Inhibition of metastasis of intraocular melanomas by adenovirus-mediated gene transfer of plasminogen activator inhibitor type 1 (PAI-1) in an athymic mouse model. Blood 90, 2738-2746.
26. Manthey, C.L., Wang, S.W., Kinney, S.D. & Yao, Z. (1998) SB202190, a selective inhibitor of p38 mitogen-activated protein kinase, is a powerful regulator of LPS-induced mRNAs in monocytes. J. Leukoc. Biol. 64, 409-417.
27. Massagué, J., Seoane, J. & Wotton, D. (2005) Smad transcription factors. Genes Dev. 19, 2783-2810.
28. Miettinen, P.J., Ebner, R., Lopez, A.R. & Derynck, R. (1994) TGF-β induced transdifferentiation of mammary epithelial cells to mesenchymal cells: Involvement of type I receptors. J. Cell Biol. 127, 2021-2036.
29. Miyazawa, K., Shinozaki, M., Hara, T., Furuya, T. & Miyazono, K. (2002) Two major Smad pathways in TGF-β superfamily signalling. Genes Cells 7, 1191-1204.
30. Miyazono, K. & Miyazawa, K. (2002) Id: A target of BMP signaling. Sci. STKE 2002, PE40.
31. Murakami, M., Ikeda, T., Saito, T., Ogawa, K., Nishino, Y., Nakaya, K. & Funaba, M. (2006) Transcriptional regulation of plasminogen activator inhibitor-1 by transforming growth factor-β, activin A and microphthalmia-associated transcription factor. Cell Signal. 18, 256-265.
32. Nishihara, A., Fujii, M., Sampath, T.K., Miyazono, K. & Reddi, A.H. (2003) Bone morphogenetic protein signaling in articular chondrocyte differentiation. Biochem. Biophys. Res. Commun. 301, 617-622.
33. Onken, M.D., Ehlers, J.P., Worley, L.A., Makita, J., Yokota, Y. & Harbour, J.W. (2006) Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas. Cancer Res. 66, 4602-4609.
34. Piek, E., Ju, W.J., Heyer, J., Escalante-Alcalde, D., Stewart, C.L., Weinstein, M., Deng, C., Kucherlapati, R., Bottinger, E.P. & Roberts, A.B. (2001) Functional characterization of transforming growth factor β signaling in Smad2- and Smad3-deficient fibroblasts. J. Biol. Chem. 276, 19945-19953.
35. Stefansson, S., McMahon, G.A., Petitclerc, E. & Lawrence, D.A. (2003) Plasminogen activator inhibitor-1 in tumor growth, angiogenesis and vascular remodeling. Curr. Pharm. Des. 9, 1545-1564.
36. Willis, S.A., Zimmerman, C.M., Li, L. & Mathews, L.S. (1996) Formation and activation by phosphorylation of activin receptor complexes. Mol. Endocrinol. 10, 367-379.
37. Yokota, Y. & Mori, S. (2002) Role of Id family proteins in growth control. J. Cell. Physiol. 190, 21-28.